The Wnt5a/Ror2 pathway is associated with determination of the differentiation fate of bone marrow mesenchymal stem cells in vascular calcification

International Journal of Molecular Medicine

Volumn 31, Issue 3, 2013, Pages 583-588

  Xin, Huaping ^a   Xin, Fang ^a   Zhou, Shaoqiong ^a   Guan, Siming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bone marrow mesenchymal stem cells; Differentiation; Vascular calcification; Wnt5a Ror2 pathway

Indexed keywords

ALKALINE PHOSPHATASE; BETA1 INTEGRIN; MESSENGER RNA; THY 1 ANTIGEN; WNT5A PROTEIN;

ANIMAL CELL; ARTICLE; BLOOD VESSEL CALCIFICATION; BONE MARROW CELL; CELL CONTACT; CELL DENSITY; CELL DIFFERENTIATION; CELL LYSATE; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; GENETIC ASSOCIATION; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; OSTEOSYNTHESIS; PHENOTYPE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; STAINING; WNT SIGNALING PATHWAY;

ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; CALCIFICATION, PHYSIOLOGIC; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; MALE; MESENCHYMAL STROMAL CELLS; MYOCYTES, SMOOTH MUSCLE; OSTEOBLASTS; OSTEOGENESIS; RATS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; RNA, MESSENGER; VASCULAR CALCIFICATION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84873143404     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1242     Document Type: Article

References (34)

1. Demer LL and Tintut Y: Vascular calcification: pathobiology of a multifaceted disease. Circulation 117: 2938-2948, 2008.
2. Tanimura A, McGregor DH and Anderson HC: Matrix vesicles in atherosclerotic calcification. Proc Soc Exp Biol Med 172: 173-177, 1983.
3. Tanimura A, McGregor DH and Anderson HC: Calcification in atherosclerosis. I. Human studies. J Exp Pathol 2: 261-273, 1986.
4. Boström KI, Rajamannan NM and Towler DA: The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res 109: 564-577, 2011.
5. Torsney E and Xu Q: Resident vascular progenitor cells. J Mol Cell Cardiol 50: 304-311, 2011.
6. Hirschi KK and Goodell MA: Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther 9: 648-652, 2002.
7. Farrington-Rock C, Crofts NJ, Doherty MJ, et al: Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 110: 2226-2232, 2004.
8. Ball SG, Shuttleworth AC and Kielty CM: Direct cell contact influences bone marrow mesenchymal stem cell fate. Int J Biochem Cell Biol 36: 714-727, 2004.
9. Dufourcq P, Descamps B, Tojais NF, et al: Secreted frizzled-related protein-1 enhances mesenchymal stem cell function in angiogenesis and contributes to neovessel maturation. Stem Cells 26: 2991-3001, 2008.
10. Cheung C and Sinha S: Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation. J Mol Cell Cardiol 51: 651-664, 2011.
11. Zhao Y, Liu YX, Xie SL, Deng BQ, Wang JF and Nie RQ: Increased expression of granulocyte colony stimulating factor mediates mesenchymal stem cells recruitment after vascular injury. Chin Med J 124: 4286-4292, 2011.
12. Roorda BD, Elst A, Boer TG, Kamps WA and de Bont ES: Mesenchymal stem cells contribute to tumor cell proliferation by direct cell-cell contact interactions. Cancer Invest 28: 526-534, 2010.
13. Abedin M, Tintut Y and Demer LL: Mesenchymal stem cells and the artery wall. Circ Res 95: 671-676, 2004.
14. Kirton JP, Crofts NJ, George SJ, Brennan K and Canfield AE: Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to vascular disease? Circ Res 101: 581-589, 2007.
15. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP and Towler DA: Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 115: 1210-1220, 2005.
16. Ishitani T, Kishida S, Hyodo-Miura J, et al: The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23: 131-139, 2003.
17. Sun S, Guo Z, Xiao X, et al: Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cells 21: 527-535, 2003.
18. Minguell JJ, Erices A and Conget P: Mesenchymal stem cells. Exp Biol Med 226: 507-520, 2001.
19. Leskela HV, Risteli J, Niskanen S, Koivunen J, Ivaska KK and Lehenkari P: Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem Biophys Res Commun 311: 1008-1013, 2003.
20. Pal SN, Clancy P and Golledge J: Circulating concentrations of stem-cell-mobilizing cytokines are associated with levels of osteoprogenitor cells and aortic calcification severity. Circ J 75: 1227-1234, 2011.
21. Baksh D and Tuan RS: Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol 212: 817-826, 2007.
22. Yip CY and Simmons CA: The aortic valve microenvironment and its role in calcific aortic valve disease. Cardiovasc Pathol 20: 177-182, 2011.
23. Rogers GJ, Hodgkin MN and Squires PE: E-cadherin and cell adhesion: a role in architecture and function in the pancreatic islet. Cell Physiol Biochem 20: 987-994, 2007.
24. Yue XS, Murakami Y, Tamai T, Nagaoka M, Cho CS, Ito Y and Akaike T: A fusion protein N-cadherin-Fc as an artificial extracellular matrixm surface for maintenance of stem cell features. Biomaterials 31: 5287-5296, 2010.
25. Cheng CW, Yeh JC, Fan TP, Smith SK and Charnock-Jones DS: Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration. Biochem Biophys Res Commun 365: 285-290, 2008.
26. Bennett CN, Longo KA, Wright WS, et al: Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 102: 3324-3329, 2005.
27. Gaur T, Lengner CJ, Hovhannisyan H, et al: Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280: 33132-33140, 2005.
28. Pohjolainen V, Taskinen P, Soini Y, et al: Noncollagenous bone matrix proteins as a part of calcific aortic valve disease regulation. Hum Pathol 39: 1695-1701, 2008.
29. Grumolato L, Liu G, Mong P, Mudbhary R, et al: Canonical and non-canonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 24: 2517-2530, 2010.
30. Qiu W, Chen L and Kassem M: Activation of non-canonical Wnt/JNK pathway by Wnt3a is associated with differentiation fate determination of human bone marrow stromal (mesenchymal) stem cells. Biochem Biophys Res Commun 413: 98-104, 2011.
31. Yuan Y, Niu CC, Deng G, Li ZQ, Pan J, Zhao C, Yang ZL and Si WK: The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells. Int J Mol Med 27: 63-69, 2011.
32. Niessen K and Karsan A: Notch signaling in cardiac development. Circ Res 102: 1169-1181, 2008.
33. Bhatt PM, Lewi CJ, House DL, et al: Increased Wnt5a mRNA expression in advanced atherosclerotic lesions, and oxidized LDL treated human monocyte-derived macrophages. Open Circ Vasc J 5: 1-7, 2012.
34. Mikels A, Minami Y and Nusse R: Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling. J Biol Chem 284: 30167-30176, 2009.